Minerva Neurosciences
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Minerva Neurosciences generated cash of -$14,784,732, which is more than the previous year. Cash used in financing activities reached the amount of $19,603,701 last year. Net change in cash is therefore $4,818,969.
Cash Flow
| 2014 | -35.96M | 1.08M | 51.60M |
|---|---|---|---|
| 2015 | -24.26M | -18.32M | 38.33M |
| 2016 | -25.68M | 17.81M | 76.56M |
| 2017 | 3.09M | -107.18M | 47.16M |
| 2018 | -41.94M | 69.48M | -3.34M |
| 2019 | -43.43M | 14.08M | 524.99K |
| 2020 | -33.82M | 24.52M | 13.23M |
| 2021 | -24.60M | 0 | 60M |
| 2022 | -24.64M | -16.32K | -5 |
| 2023 | -14.78M | 0 | 19.60M |
NERV Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 36.19M | 60.85M | 25.45M | 21.51M | 50.33M | 26.13M | 82.98M | 14.28M | 18.54M | 1.81M |
Operating activities | ||||||||||
Net income | -30.00M | -32.10M | -49.90M | 1.94M | -72.18M | -50.17M | -31.52M | -31.04M | -27.08M | -56.90M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 30.98K | 8.51K | 101.78K | 176.17K | 161.50K | 17.46K | 11.09K | 16.53K | 17.27K | 33.86K |
Stock-based compensation expense | 1.96M | 4.10M | 5.21M | 9.70M | 9.17M | 0 | 5.03M | 3.57M | 2.20M | 17.96M |
| Deferred income tax benefit | 1.96M | 4.10M | 5.21M | 9.70M | 9.17M | 0 | 5.03M | 3.57M | 2.20M | 17.96M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 0 | -3.11M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 3.11M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts payable | 835.65K | -883.54K | 857.60K | -1.32M | 517.33K | 364.03K | -32.70K | 107.77K | 718.75K | 368.69K |
Cash generated by operating activities | -14.78M | -24.64M | -24.60M | -33.82M | -43.43M | -41.94M | 3.09M | -25.68M | -24.26M | -35.96M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | -3.87M | -61.09M | -40.66M | -134.52M | 0 | -23.27M | 0 |
Investments In Property Plant And Equipment | 2 | -16.32K | 0 | 0 | 0 | 0 | -52.4K | 0 | 0 | -45.60K |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 0 | 52.4M | 0 | 0 | 1.16M |
Cash generated by investing activities | 0 | -16.32K | 0 | 24.52M | 14.08M | 69.48M | -107.18M | 17.81M | -18.32M | 1.08M |
Financing activities | ||||||||||
Common Stock Issued | 19.99M | 0 | 0 | 12.55M | 524.99K | 655.93K | 44.56M | 58.49M | 30.99M | 55.04M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | -389 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | 0 | 0 | 0 | -4.00M | -4.93M | -1.57M | 10M | -1.88M |
Cash used in financing activities | 19.60M | -5 | 60M | 13.23M | 524.99K | -3.34M | 47.16M | 76.56M | 38.33M | 51.60M |
Net Change In Cash | 4.81M | -24.66M | 35.39M | 3.94M | -28.82M | 24.20M | -56.92M | 68.69M | -4.26M | 16.72M |
Cash at end of period | 41.01M | 36.19M | 60.85M | 25.45M | 21.51M | 50.33M | 26.05M | 82.98M | 14.28M | 18.54M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |